Ligand Binding Studies of Caspase 3 Protein with Compounds of Bacopa monneri - A Target Protein Responsible for Alzheimer's Disease (AD)

被引:0
|
作者
Johari, Surabhi [1 ]
Sinha, Subrata [1 ]
Bora, Sewali [1 ]
Biswas, Sagarika [2 ]
Gupta, Khushboo [1 ]
机构
[1] Dibrugarh Univ, Ctr Bioinformat Studies, Dibrugarh, Assam, India
[2] Univ Delhi, CSIR Lab, Inst Genom & Integrat Biol, Delhi, India
来源
GLOBAL TRENDS IN COMPUTING AND COMMUNICATION SYSTEMS, PT 1 | 2012年 / 269卷
关键词
Alzheimer's Disease; Caspases; CASP; 3; Bacopa monneri; Ligand; STRUCTURE-PROPERTY; ACCURACY; DOCKING;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Alzheimer's disease (AD) is a type of dementia that causes problems with memory, thinking and behaviour. It has been discovered that APP (amyloid precursor protein) is a precusor molecule whose proteolysis generate amyloid B (AB) amino acid peptide. AB is an amyloidogenic peptide that forms senile plaques found in the brains of AD. Evidence suggests that senile plaques are formed due to the activation of Caspases particulary caspases CASP 3 and CASP 4. Bacopa monneri has been in use since early as a brain tonic to enhance memory development, however how the components of Bacopa monneri function is yet unknown In this paper an attempt has been made to establish the components activities insilico with CASP 3. We found that among the screened seven compounds Ligand 6 interacts potentially with CASP 3 and has passed all the properties of drug with drug likeliness 0.95, drug score 0.69, highly soluble, highly permeable, non mutagenic, non tumerogenic and non irritant.
引用
收藏
页码:37 / +
页数:3
相关论文
共 50 条
  • [21] Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain
    Taguchi, J
    Fujii, A
    Fujino, Y
    Tsujioka, Y
    Takahashi, M
    Tsuboi, Y
    Wada, I
    Yamada, T
    ACTA NEUROPATHOLOGICA, 2000, 100 (02) : 153 - 160
  • [22] Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease
    Wei, Hui
    Zhang, Hui-liang
    Xie, Jia-zhao
    Meng, Dong-li
    Wang, Xiao-chuan
    Ke, Dan
    Zeng, Ji
    Liu, Rong
    CURRENT MEDICAL SCIENCE, 2020, 40 (01) : 1 - 8
  • [23] Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
    Zhang, Tao
    Kim, Byeong Mo
    Lee, Tae Ho
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01)
  • [24] Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols
    Zhang, Meng
    Hu, Guanhua
    Shao, Nan
    Qin, Yunpeng
    Chen, Qian
    Wang, Yan
    Zhou, Peng
    Cai, Biao
    INFLAMMOPHARMACOLOGY, 2021, 29 (05) : 1317 - 1329
  • [25] Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis
    Podder, Avijit
    Pandit, Mansi
    Narayanan, Latha
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2018, 22 (10) : 665 - 677
  • [26] Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
    Reddy, P. Hemachandra
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (01): : 67 - 75
  • [27] Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
    Tao Zhang
    Byeong Mo Kim
    Tae Ho Lee
    Translational Neurodegeneration, 13
  • [28] Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols
    Meng Zhang
    Guanhua Hu
    Nan Shao
    Yunpeng Qin
    Qian Chen
    Yan Wang
    Peng Zhou
    Biao Cai
    Inflammopharmacology, 2021, 29 : 1317 - 1329
  • [29] The mitochondrial protein TSPO in Alzheimer’s disease: relation to the severity of AD pathology and the neuroinflammatory environment
    Emma F. Garland
    Oliver Dennett
    Laurie C. Lau
    David S. Chatelet
    Michel Bottlaender
    James A. R. Nicoll
    Delphine Boche
    Journal of Neuroinflammation, 20
  • [30] The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment
    Garland, Emma F.
    Dennett, Oliver
    Lau, Laurie C.
    Chatelet, David S.
    Bottlaender, Michel
    Nicoll, James A. R.
    Boche, Delphine
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)